Daiichi Sankyo (PK) Stock Quote DSKYF - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

35.29

Bid

32.39

Ask

36.90

Volume

0.00 Day's Range 0.00

23.45 52 Week Range 44.64

Market Cap

67.643B

Previous Close

35.29

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

2,689

Shares Outstanding

1,916,787,029

Dividend Yield

14,269.47%

PE Ratio

0.34

Earnings Per Share (EPS)

104.72

Revenue

1.63T

Net Profit

200.73B

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Biolog/vaccines

Website

www.daiichisankyo.co.jp

Headquarters

Chuo, Tokyo, Jpn

Founded

2005

Daiichi Sankyo Co Ltd (PK) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker DSKYF. The last closing price for Daiichi Sankyo (PK) was $35.29. Over the last year, Daiichi Sankyo (PK) shares have traded in a share price range of $ 23.45 to $ 44.64.

Daiichi Sankyo (PK) currently has 1,916,787,029 shares outstanding. The market capitalization of Daiichi Sankyo (PK) is $67.64 billion. Daiichi Sankyo (PK) has a price to earnings ratio (PE ratio) of 0.34.

Daiichi Sankyo's Once-Daily Lixiana® (edoxaban) Approved for the Prevention of Stroke and Systemic Embolism in Non-Valvular ...

Daiichi Sankyo's Once-Daily Lixiana® (edoxaban) Approved for the Prevention of Stroke and Systemic Embolism in Non-Valvular Atrial Fibrillation and for the Treatment and Prevention of Recurrent...

Daiichi Sankyo, Inc. and Asubio Pharmaceuticals, Inc. Merge

Daiichi Sankyo, Inc. and Asubio Pharmaceuticals, Inc. Merge PR Newswire PARSIPPANY, N.J., April 1, 2015 PARSIPPANY, N.J., April 1, 2015 /PRNewswire/ -- Daiichi Sankyo, Inc., the US subsidiary of...

Venue Change

Tue, Oct 08, 2013 12:00 - Daiichi Sankyo Co., Ltd. (DSKYF: OTC Link) - Venue Change - The symbol, DSKYF, no longer trades on Grey Market. As of Tue, Oct 08, 2013, DSKYF trades on OTC Link. You...

Glaxo Files for Two Flu Vaccines - Analyst Blog

Recently, GlaxoSmithKline (GSK) announced that it has filed marketing applications for two influenza vaccines. The vaccines, up for approval, include a quadrivalent influenza vaccine for the...

Glaxo and Daiichi to Set Up JV - Analyst Blog

British drugmaker GlaxoSmithKline (GSK) recently announced that it has signed an agreement with Daiichi Sankyo (DSKYF) to form a joint venture (JV). The JV will be called Japan Vaccine Co., Ltd...

Daiichi Sankyo, Inc. Names Danesha Dixon Smith Vice President of Human Resources

Daiichi Sankyo, Inc. Names Danesha Dixon Smith Vice President of Human Resources PR Newswire PARSIPPANY, N.J., June 28, 2011 PARSIPPANY, N.J., June 28, 2011 /PRNewswire/ -- Daiichi Sankyo, Inc...

John P. Gargiulo Named President and CEO of Daiichi Sankyo, Inc.

John P. Gargiulo Named President and CEO of Daiichi Sankyo, Inc. PR Newswire PARSIPPANY, N.J., April 4, 2011 PARSIPPANY, N.J., April 4, 2011 /PRNewswire/ -- Daiichi Sankyo, Inc. (DSI) announced...

Update: Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fib

Update: Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fibrillation - More Than 21,000 Patients Enrolled in the Largest...

Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fibrillatio

Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fibrillation - More Than 21,000 Patients Enrolled in the Largest Clinical...

ArQule and Daiichi Sankyo Expand Drug Discovery Collaboration in Oncology

ArQule and Daiichi Sankyo Expand Drug Discovery Collaboration in Oncology PR Newswire WOBURN, Massachusetts, October 12, 2010 WOBURN, Massachusetts, October 12, 2010 /PRNewswire/ -- ArQule, Inc...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-2.05	-5.49009105517	37.34	37.34	32.41	2682	36.37520094	CS
4	-3.27	-8.48029045643	38.56	44.64	32.41	3014	38.1418894	CS
12	0.59	1.70028818444	34.7	44.64	32.41	2689	37.95865294	CS
26	2.87	8.85256014806	32.42	44.64	28.22	15904	32.1342513	CS
52	7.29	26.0357142857	28	44.64	23.45	10364	31.30282581	CS
156	6.48	22.4921902117	28.81	44.64	19.45	7931	30.06107608	CS
260	-29.06	-45.1592851593	64.35	95.96	17.61	6382	30.89791664	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AABVFAberdeen International Inc (PK)	$ 0.03115 (0.00%)	0
AABKFAareal Bank AG (PK)	$ 0.00 (0.00%)	0
AABBAsia Broadband Inc (PK)	$ 0.03415 (0.00%)	0
AAALYAareal Bank AG (PK)	$ 34.65 (0.00%)	0
AAAIFAlternative Investment Trust (PK)	$ 0.55 (0.00%)	0
AABVFAberdeen International Inc (PK)	$ 0.03115 (0.00%)	0
AABKFAareal Bank AG (PK)	$ 0.00 (0.00%)	0
AABBAsia Broadband Inc (PK)	$ 0.03415 (0.00%)	0
AAALYAareal Bank AG (PK)	$ 34.65 (0.00%)	0
AAAIFAlternative Investment Trust (PK)	$ 0.55 (0.00%)	0
OGCIFOceanaGold Philippines Inc OGP (GM)	$ 0.00 (0.00%)	800k
XIACFXiaomi Corporation (PK)	$ 2.5447 (0.00%)	500k
CHFLFChina Feihe Ltd (PK)	$ 0.407 (0.00%)	500k
DOCMFDr Martens PLC (PK)	$ 0.72 (0.00%)	450k
SHTDYSinopharm Group Company Ltd (PK)	$ 11.04 (0.00%)	386.21k